Bizarre Patents
Neuroimaging as a Marketing Tool
Neuroimaging as a means for validating whether a stimulus such as advertisement, communication, or product evokes a certain mental response such as emotion, preference, or memory, or to predict the consequences of the stimulus on later behavior such as consumption or purchasing.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7271200 | Emulsions A novel emulsion comprising a material which is stabilised by a polymer resin precursor having interface active molecules incorporated therein by reaction from poorly or non-surface active materials is disclosed. The process for producing such emulsions is likewise ... | 09/18/2007 |
| 7166276 | Silicone elastomer emulsion cosmetic composition comprising colorant inclusive internal phase The present invention relates to silicone elastomer emulsion cosmetic compositions that comprise an internal phase the further includes a colorant. These compositions are intended to deliver such colorant ingredients to the skin of the user in such a manner as to pr... | 01/23/2007 |
| 7144919 | Polyoxyethylene-polyoxypropylene vitamin E and process for preparation thereof The present invention relates to polyoxyethylene-polyoxypropylene (POE-POP) vitamin E, which is prepared from vitamin E by polyethoxylation and polypropoxylation, and a method for preparing the same. The POE-POP vitamin E has a high surface activity and an excellent... | 12/05/2006 |
| 7081253 | Use of nanodispersions in pharmaceutical end formulations A description is given of the use of a nanodispersion, which comprises (a) a membrane-forming molecule, (b) a coemulsifier and (c) a lipophilic component, in pharmaceutical end for... | 07/25/2006 |
| 7074824 | Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same Beta-lapachone, which is poorly soluble in most pharmaceutically acceptable solvents, has demonstrated significant antineoplastic activity against human cancer lines. The present invention overcomes this significant limitation by teaching novel pharmaceutical compos... | 07/11/2006 |
| 7015279 | Composition and method for preparing novel cationic thickeners A composition and method for a linear or crosslinked cationic polyelectrolyte, involving copolymerization of at least one cationic monomer with at least one neutral monomer and at least one nonionic surfactant monomer. ... | 03/21/2006 |
| 6995209 | Thermally reversible water in oil in water emulsions A thermally reversible water in oil in water (W/O/W) emulsion including a thermally reversible viscosifying polymer in the continuous aqueous phase of the emulsion. The thermally reversible viscosifying polymer of the W/O/W emulsion includes a block copolymer having... | 02/07/2006 |
| 6962944 | Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same Beta-lapachone, which is poorly soluble in most pharmaceutically acceptable solvents, has demonstrated significant antineoplastic activity against human cancer lines. The present invention overcomes this significant limitation by teaching novel pharmaceutical compos... | 11/08/2005 |
| 6958157 | Triiodomethane thickener conjugates, a method for their production and their use as disinfectant cleaners and hygiene products The invention relates to a new conjugate, based on triiodomethane, which also contains at least one natural organic and/or modified natural organic and/or inorganic thickener. Cellulose ethers or starch ethers are particularly suitable for use as the thickener. Said... | 10/25/2005 |
| 6955818 | Pour-on formulations A non-irritant topically acceptable carrier selected from the group consisting of: a) i) at least one of tripropylene glycol methyl ether and dipropylene glycol methyl ether, and ii) at least one of alcohol, wool grease and propylene glycol, wherein (i) is present i... | 10/18/2005 |
| 6946426 | Process to prepare aqueous formulations Provided is a method of formulating hydrophobic pesticides comprising emulsifying an aqueous phase and a water-immiscible phase to form a formulation; wherein the aqueous phase is comprised of water and optionally a freeze/thaw agent, one or more emulsifiers, or com... | 09/20/2005 |
| 6896897 | Flexible applicator for applying oil-in-water emulsion with improved stability A flexible applicator for applying an oil-in-water emulsion comprises: (1) an allantoin-containing oil-in-water emulsion; and (2) a flexible element that adsorbs or absorbs the emulsion such that the emulsion is applied to the skin of a patient on whom the flexible ... | 05/24/2005 |
| 6864274 | Allantoin-containing skin cream An allantoin-containing skin cream composition can comprise allantoin and at least one anionic or nonionic emulsifier that is substantially hydrophilic and is soluble in water. The pH of the composition is in a range of from about 3.0 to about 6.0; preferably, the p... | 03/08/2005 |
| 6855332 | Absorption promoting agent The present invention relates to pharmaceutical compositions comprising polyoxyethylene glycol, fatty acid mono- and diglyceride ester as an absorption promoting agent and an absorption controlling agent together with a therapeutically, prophylactically and/or diagn... | 02/15/2005 |
| 6831107 | Emulsification systems and emulsions Personal care or cosmetic oil in water emulsions include an oil emulsifier and a combination of a Xanthan polysaccharide and a polyglucomannan polysaccharide to provide enhanced stability even at low emulsifier stabiliser levels. The emulsifier stabiliser system pro... | 12/14/2004 |
| 6710092 | Emulsions A novel emulsion comprising a material which is stabilized by a polymer resin precursor having interface active molecules incorporated therein by reaction from poorly or non-surface active materials is disclosed. The process for producing such emulsions is likewise ... | 03/23/2004 |
| 6673826 | Methods for treatment of inflammatory diseases An improved method of treating skin diseases comprises applying to the skin of a patient suffering such a skin disease an allantoin-containing composition in a therapeutically effective quantity. The allantoin-containing composition is a water-in-oil emul... | 01/06/2004 |
| 6673360 | Technique for emulsifying highly saturated hydroisomerized fluids A preferred emulsifier blend includes ethoxylated alcohols containing hydrocarbons of C10-C16 and preferably having on average at least 2.8 ethoxy and/or alcohol groups per chain and a glycerol mono- and/or dioleates, preferably in a ratio of from 9:1 to ... | 01/06/2004 |
| 6667044 | Cosmetic or dermatological gels based on microemulsions Microemulsion gels a) based on water in oil type microemulsions, comprising an oil phase which is essentially composed of not easily volatile components, an aqueous phase containing one or more polyethoxylated W/O emulsifiers and/or one or more polypropox... | 12/23/2003 |
| 6660252 | Low emulsifier multiple emulsions The invention relates to multiple emulsions comprising a primary emulsion in an external phase, and comprising a principle water phase and a principle oil phase, the multiple emulsion containing no more than about 1% of an emulsifier having an HLB of abou... | 12/09/2003 |
| 6660278 | Controlled release composition A controlled release composition for a biologically active material, which composition is liquid or liquid crystalline and comprises at least one medium or long-chain fatty acid ester of diglycerol as a carrier for said biologically active material, said ... | 12/09/2003 |
| 6635240 | Hair styling compositions containing select polyalkylene glycol styling agents Disclosed are hair styling compositions which comprise from about 5% to about 90% by weight of a polyalkylene glycol styling agent that is substantially free of polyalkylene glyceryl ethers, and that has a number average molecular weight of from about 190... | 10/21/2003 |
| 6627603 | Method for releasing an active principle contained a multiple emulsion A method for the controlled release of an active principle contained in a multiple water-in-oil-in-water emulsion characterized in that the multiple emulsion comprises an invert emulsion Ei with an aqueous phase A1 containing at least a hydrophilic active... | 09/30/2003 |
| 6613338 | Cosmetic and skin care sticks with high water contents Lipsticks, antiacne sticks, sunscreen sticks and eyeshadow sticks, with a high water content, characterized in that they comprise (a) a lipid phase, which comprises (a1) at least one oil component (a2) at least one wax component (a3) optionally othe... | 09/02/2003 |
| 6607733 | Cosmetic or dermatological gels based on microemulsions Microemulsion gels based on microemulsions of the oil-in-water type in which the droplets of the discontinuous oily phase are joined to one another by one or more crosslinking substances, the molecules of which are distinguished by at least one hydrophili... | 08/19/2003 |
| 6602511 | Microemulsions for use as vehicles for administration of active compounds A non-toxic oil-in-water or bicontinous microemulsion used as a pharmaceutically acceptable vehicle for administration of one or more active compounds having a low solubility in water as well as a process for the preparation and the use thereof.... | 08/05/2003 |
| 6576678 | W/O emulsion bases The invention relates to emulsion bases containing (a) polyol poly-12-polyhydroxystearates, (b) polyol esters selected from the group consisting of sorbitan esters, oligoglycerol esters and partial glycerides, (c) citric acid esters, (d) waxes and (e) metal soaps. ... | 06/10/2003 |
| 6565859 | Galenical formulations A pharmaceutical composition containing macrolide, e.g. a rapamycin compound in an emulsion preconcentrate or microemulsion preconcentrate for oral administration. The carrier medium for the rapamycin compound includes a hydrophilic phase, a lipophilic ph... | 05/20/2003 |
| 6548073 | Two-phase cosmetic composition The present invention refers to a two-phase cosmetic composition including an aqueous phase and an oily phase wherein the aqueous phase contains an emulsifying system comprising at least one surfactant selected from the group of cationic surfactants and a... | 04/15/2003 |
| 6541018 | Nanoemulsion based on glycerol fatty esters, and its uses in the cosmetics, dermatological and/or ophthalmological fields The present invention provides a nanoemulsion, that includes: an oily phase dispersed in an aqueous phase; and at least one glycerol fatty ester surfactant which is solid at a temperature of less than or equal to 45° C.; wherein the oily phase includes oil globule... | 04/01/2003 |
| 6531500 | Methods for treatment of inflammatory diseases An improved method of treating skin diseases comprises applying to the skin of a patient suffering such a skin disease an allantoin-containing composition in a therapeutically effective quantity. The allantoin-containing composition is a water-in-oil emul... | 03/11/2003 |
| 6506396 | Stable medicated animal care formulation A stable medicated animal care formulation including, by weight; (a) 0.1-10% of an active agricultural ingredient, of an animal care and/or veterinary reagents, (b) 0.0002-40% of a microemulsion concentrate including: (i) 0-10% of a castor oil ethoxylate or tristyr... | 01/14/2003 |
| 6506391 | Cosmetic or dermatological composition in the form of a dispersion of an oily phase and an aqueous phase, stabilized with cubic gel particles W/O or O/W stable dispersions are formed by mixing an oily phase and an aqueous phase when the dispersion is stabilized with cubic gel particles formed by the combination of two amphiphilic compounds, one of the amphiphilic compounds being capable of form... | 01/14/2003 |
| 6461622 | Topical compositions Skin care compositions comprising an oil-in-water emulsion base containing retinoids and possessing good physical and chemical stability.... | 10/08/2002 |
| 6458383 | Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin A delayed release pharmaceutical dosage form for oral administration of a hydrophilic drug, e.g., a polysaccharide drug such as low molecular weight heparin, are provided. The dosage form comprises a composition of: (a) a therapeutically effective amount ... | 10/01/2002 |
| 6451339 | Compositions and methods for improved delivery of hydrophobic agents The present invention relates to triglyceride-free pharmaceutical compositions for delivery of hydrophobic therapeutic agents. Compositions of the present invention include a hydrophobic therapeutic agent and a carrier, where the carrier is formed from a ... | 09/17/2002 |
| 6419949 | Microparticles for drug delivery across mucosa and the blood-brain barrier Pharmaceutical composition comprising micro particles having an average diameter ranging from 40 to 150 nm, consisting of one or more lipids, a drug and, optionally, a steric stabilizer, suitable to the transmucosal passage and to the overcoming of the bl... | 07/16/2002 |
| 6346553 | Alkylmethylsiloxane-dimethylsilicone polyalkylene oxide copolymers Alkylmethylsiloxane-dimethylsiloxane polyalkylene oxide copolymers useful as surfactants for both oil-in-water emulsions and silicone-in-water emulsions are disclosed.... | 02/12/2002 |
| 6344186 | Oil-in-water emulsions containing a 1,3,5-triazine derivative and a copolyol silicone and cosmetic applications The present application relates to novel oil-in-water emulsions comprising i) at least one specific 1,3,5-triazine derivative and ii) at least one polyalkyl-polyethersiloxane carrying polyoxyalkylene groups grafted onto the main silicone chain; with the p... | 02/05/2002 |
| 6335022 | Nanoemulsion based on oxyethylenated or non-oxyethylenated sorbitan fatty esters, and its uses in the cosmetics, dermatological and/or ophthalmological fields The present invention relates to a nanoemulsion, the oil globules of which have an average size of less than 100 nm, comprising (1) a surfactant which is solid at a temperature of less than or equal to 45° C., which surfactant is chosen from sorbitan fat... | 01/01/2002 |
